In Person Event

https://www.pathologynews.com/wp-content/uploads/2025/05/ESDIP-Logo-1.png Continuing ESDIP’s tradition of fostering a dynamic, interdisciplinary community, ECDP2026 will bring together experts from pathology, computer science, molecular biology, clinical medicine, and industry. The congress will serve as a platform for scientific exchange, hands-on experiences, and strategic discussions around the rapidly evolving field of Digital and Computational Pathology. The 2026 edition will focus on the [...]

https://www.pathologynews.com/wp-content/uploads/2025/10/Convenzis-Logo.png Clinical Diagnostics & Medical Sciences Pathology services are integral to the NHS, supporting over 70% of clinical diagnoses. As demands on pathology continue to grow, innovation in digital pathology, automation, and workforce management is essential. This conference will explore the latest advancements and strategies for ensuring efficiency, accuracy, and service sustainability. Key Topics: Digital pathology and [...]

Advancing Urology Diagnostics Through Clinical Innovation Join Source Cambridge Clinical Laboratories for an exclusive evening of education, discussion, and networking focused on the evolving landscape of urology diagnostics and patient care. This specialist event will focus on the evolving role of advanced diagnostics in urology, exploring developments across early detection, screening, diagnosis, prognosis, and treatment decision-making. Expert [...]

Advancing Cancer Care, Restoring Hope and Lives​ KSMO 2026—the 19th Annual Meeting of the Korean Society of Medical Oncology (KSMO) and the 2026 International Conference, held in conjunction with the 14th International Conference of the Federation of Asian Clinical Oncology (FACO), will bring together oncologists, researchers, clinicians, and healthcare professionals from around the world to explore the [...]

The ESP Congresses are 5-day annual international pathology congresses by the European Society of Pathology and the largest gatherings of pathologists in Europe.  The aim is to provide an up-to-date scientific programme (e.g. keynote lectures, symposia, slide seminars, short courses, discussions) covering all major areas of diagnostic, translational, molecular and investigative pathology. Special emphasis will be put [...]

MICCAI 2026 (Medical Image Computing and Computer Assisted Intervention) is one of the world's leading conferences in medical imaging, artificial intelligence, computer-assisted interventions, and healthcare innovation. Bringing together researchers, clinicians, engineers, and industry leaders, the conference showcases the latest advances in medical image analysis, machine learning, robotics, computer vision, and AI-driven healthcare technologies. Following a recent announcement [...]

https://www.pathologynews.com/wp-content/uploads/2025/05/Terrapinn-Logo.png Data. AI. Precision. Innovation. For Pharma, Healthcare & Partners America’s most exciting biotechnology congress, bridging the gap between pharma, academia and clinicians to foster meaningful collaborations BioTechX USA covers diagnostics, precision medicine, and digital transformation in pharmaceutical development and healthcare. Now running for the third year, the event continues conversations on the East Coast, maintaining and [...]

CAP26 is where the future of pathology takes shape; where pathologists gather not just to gain knowledge, but to exchange ideas, build relationships, and reconnect around a shared vision. The conversations are real, the education is practical, and the sense of belonging is unmistakable. You’re among colleagues who understand the stakes, the challenges, and what it means [...]

Accelerating Complex Biomarkers, Novel & Multimodal Endpoints to Fuel Drug-Diagnostic Innovations from Bench-to-Bedside for Global Precision Medicine Access As regulatory headwinds turn to tailwinds, precision medicine is shifting into a new gear. Evolving FDA approaches to LDTs and 510(k) pathways are removing long-standing friction, coordinated Rx-Dx launches are gaining pace, ctDNA and MRD are advancing as clinically [...]